Related Experiment Video
Updated: Jan 20, 2026

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
Published on: May 25, 2022
Design and Production of Newcastle Disease Virus for Intratumoral Immunomodulation
Gayathri Vijayakumar1,2, Dmitriy Zamarin3,4,5
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract:
Newcastle disease virus (NDV) is an avian paramyxovirus that has been extensively studied as an oncolytic agent, in addition to being an economically important pathogen in the poultry industry. The establishment of a reverse genetics system for this virus has enabled the development of genetically modified recombinant NDV viruses with improved oncolytic and immunotherapeutic properties. In this chapter, we describe the materials and methods involved in the in vitro cloning and rescue of NDV expressing murine 4-1BBL as well as the in vivo evaluation of NDV expressing 4-1BBL in a B16-F10 murine melanoma model.
Related Concept Videos
07:24Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
10:55Rescue of Recombinant Newcastle Disease Virus from cDNA
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
07:04Optimization of Antigen Preparation for Hemagglutination Inhibition Assay of Newcastle Disease Virus Serology
09:07Murine Model of Epicutaneously-Induced Immunomodulation
10:49Estimating Virus Production Rates in Aquatic Systems

